Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:40 pm Sale | 2024-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | Great Point Partners, LLC | 2,055,834 6.880% | -674,075 (-24.69%) | Filing History |
| 2025-02-14 4:39 pm Purchase | 2024-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Great Point Partners, LLC | 11,473,166 9.990% | 1,950,734 (+20.49%) | Filing History |
| 2025-02-14 4:39 pm Purchase | 2024-12-31 | 13G | ProMIS Neurosciences, Inc. PMN | Great Point Partners, LLC | 3,334,520 9.990% | 327,337 (+10.89%) | Filing History |
| 2025-02-14 4:38 pm Sale | 2024-12-31 | 13G | Outlook Therapeutics, Inc. OTLK | Great Point Partners, LLC | 2,220,000 8.180% | -261,973 (-10.56%) | Filing History |
| 2025-02-14 4:37 pm Purchase | 2024-12-31 | 13G | OptiNose, Inc. OPTN | Great Point Partners, LLC | 896,585 8.470% | 896,585 (New Position) | Filing History |
| 2025-02-14 4:33 pm Sale | 2024-12-31 | 13G | Context Therapeutics Inc. CNTX | Great Point Partners, LLC | 4,683,711 6.250% | -2,251,271 (-32.46%) | Filing History |
| 2025-02-14 4:32 pm Sale | 2024-12-31 | 13G | Zura Bio Limited ZURA | Great Point Partners, LLC | 3,170,194 4.860% | -93,478 (-2.86%) | Filing History |
| 2025-02-14 4:31 pm Sale | 2024-12-31 | 13G | Neurogene Inc. NGNE | Great Point Partners, LLC | 442,761 2.980% | -561,530 (-55.91%) | Filing History |
| 2024-11-14 5:06 pm Sale | 2024-09-30 | 13G | Zura Bio Limited ZURA | Great Point Partners, LLC | 3,263,672 5.120% | -31,328 (-0.95%) | Filing History |
| 2024-11-14 5:05 pm Sale | 2024-09-30 | 13G | VistaGen Therapeutics, Inc. VTGN | Great Point Partners, LLC | 2,729,909 9.380% | -63,018 (-2.26%) | Filing History |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY | Great Point Partners, LLC | 9,522,432 9.990% | 963,432 (+11.26%) | Filing History |
| 2024-11-14 4:56 pm Purchase | 2024-09-30 | 13G | ProMIS Neurosciences, Inc. PMN | Great Point Partners, LLC | 3,007,183 9.990% | 1,485 (+0.05%) | Filing History |
| 2024-11-14 4:55 pm Purchase | 2024-09-30 | 13G | Outlook Therapeutics, Inc. OTLK | Great Point Partners, LLC | 2,481,973 9.990% | 250,649 (+11.23%) | Filing History |
| 2024-11-14 4:54 pm Purchase | 2024-09-30 | 13G | OptiNose, Inc. OPTN | Great Point Partners, LLC | 1,020,463 9.990% | 254,855 (+33.29%) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | Neurogene Inc. NGNE | Great Point Partners, LLC | 1,004,291 7.730% | 10,062 (+1.01%) | Filing History |
| 2024-11-14 4:52 pm Sale | 2024-09-30 | 13G | Context Therapeutics Inc. CNTX | Great Point Partners, LLC | 6,934,982 9.250% | -484,373 (-6.53%) | Filing History |
| 2024-11-14 4:47 pm Sale | 2024-09-30 | 13G | UroGen Pharma Ltd. URGN | Great Point Partners, LLC | 758,786 1.800% | -1,861,759 (-71.04%) | Filing History |
| 2024-11-14 4:46 pm Sale | 2024-09-30 | 13G | Elevation Oncology, Inc. ELEV | Great Point Partners, LLC | 0 0.000% | -3,877,172 (Position Closed) | Filing History |
| 2024-11-14 4:45 pm Sale | 2024-09-30 | 13G | Alpine Immune Sciences, Inc. ALPN | Great Point Partners, LLC | 0 0.000% | -3,703,433 (Position Closed) | Filing History |
| 2024-08-15 4:03 pm Purchase | 2024-08-06 | 13G | Elevation Oncology, Inc. ELEV | Great Point Partners, LLC | 3,877,172 6.560% | 3,877,172 (New Position) | Filing History |